Menu
Cardiovascular Disease

VANISH Trial: VT Ablation versus Escalation of Antiarrhythmic Drugs

  • admin
  • May 02, 2020 // Modified 2 weeks ago

Share this:

  • Twitter
  • Facebook
Tags: ablation, antiarrhthmic drugs, ICD, MI, tachycardia, ventricular tachycardia, VT
Print
Share this

Related Articles

  • TECOS Trial: Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

  • SURTAVI Trial: Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

  • SURVIVE Trial: Levosimendan vs dobutamine for patients with acute decompensated heart failure

  • TWILIGHT Trial: Ticagrelor with or without Aspirin in High-Risk Patients after PCI

Social

  • Facebook
  • Twitter
  • Instagram
© Copyright 2020 Visualmed - Designed by ThemeWarrior